Literature DB >> 25373531

Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

J de Castro1, M Cobo, D Isla, J Puente, N Reguart, B Cabeza, A Gayete, M Sánchez, M I Torres, J Ferreirós.   

Abstract

The last decade has seen substantial progress in the diagnostic and therapeutic approach to lung cancer, thus meaning that its prognosis has improved. The Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology have therefore produced a national consensus statement to make recommendations for radiological diagnosis and assessment of treatment response in patients with lung cancer. This expert group recommends multi-detector computed tomography as the technique of choice for investigating this disease. The radiology report should include a full assessment by the TNM staging system. Lastly, when the patient is on immunotherapy, response evaluation should employ not only response evaluation criteria in solid tumours, but also immune-related response criteria.

Entities:  

Mesh:

Year:  2014        PMID: 25373531     DOI: 10.1007/s12094-014-1231-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  56 in total

1.  Low-dose CT of the lung: potential value of iterative reconstructions.

Authors:  Stephan Baumueller; Anna Winklehner; Christoph Karlo; Robert Goetti; Thomas Flohr; Erich W Russi; Thomas Frauenfelder; Hatem Alkadhi
Journal:  Eur Radiol       Date:  2012-06-15       Impact factor: 5.315

2.  New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.

Authors:  Mizuki Nishino; David M Jackman; Hiroto Hatabu; Beow Y Yeap; Leigh-Anne Cioffredi; Jeffrey T Yap; Pasi A Jänne; Bruce E Johnson; Annick D Van den Abbeele
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

3.  New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy.

Authors:  Ho Yun Lee; Kyung Soo Lee; Myung-Ju Ahn; Hye Sun Hwang; Ju Won Lee; Keunchil Park; Jin Seok Ahn; Tae Sung Kim; Chin A Yi; Myung Jin Chung
Journal:  Lung Cancer       Date:  2010-11-18       Impact factor: 5.705

4.  Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation.

Authors:  H S Glazer; L R Kaiser; D J Anderson; P L Molina; B Emami; C L Roper; S S Sagel
Journal:  Radiology       Date:  1989-10       Impact factor: 11.105

5.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  S Peters; A A Adjei; C Gridelli; M Reck; K Kerr; E Felip
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

6.  Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.

Authors:  Vahid Yaghmai; Frank H Miller; Pedram Rezai; Al B Benson; Riad Salem
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

7.  Visceral pleural invasion classification in non-small cell lung cancer.

Authors:  Akikazu Kawase; Junji Yoshida; Genichiro Ishii; Tomoyuki Hishida; Mitsuyo Nishimura; Kanji Nagai
Journal:  J Thorac Oncol       Date:  2010-11       Impact factor: 15.609

8.  Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation.

Authors:  Morie M Chen; Fergus V Coakley; Anjali Kaimal; Russell K Laros
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

Review 9.  Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

Authors:  I M E Desar; C M L van Herpen; H W M van Laarhoven; J O Barentsz; W J G Oyen; W T A van der Graaf
Journal:  Cancer Treat Rev       Date:  2009-01-10       Impact factor: 12.111

10.  Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.

Authors:  Shu-Hua Ma; Hong-Bo Le; Bao-hui Jia; Zhao-Xin Wang; Zhuang-Wei Xiao; Xiao-Ling Cheng; Wei Mei; Min Wu; Zhi-Guo Hu; Yu-Guang Li
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

View more
  4 in total

1.  Current radiation therapy techniques for lung cancer and its importance for suitable radiological assessment of treatment response in lung cancer.

Authors:  J J Cabrera Rodríguez
Journal:  Clin Transl Oncol       Date:  2015-04-08       Impact factor: 3.405

2.  Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.

Authors:  M Majem; J Hernández-Hernández; F Hernando-Trancho; N Rodríguez de Dios; A Sotoca; J C Trujillo-Reyes; I Vollmer; R Delgado-Bolton; M Provencio
Journal:  Clin Transl Oncol       Date:  2019-06-06       Impact factor: 3.405

3.  Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC).

Authors:  Cesare Gridelli; Andrea Camerini; Giovanni Pappagallo; Angelo Pennella; Michele Anzidei; Massimo Bellomi; Roberta Buosi; Rosario Francesco Grasso
Journal:  Cancer Imaging       Date:  2016-12-28       Impact factor: 3.909

4.  Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.

Authors:  Laure Fournier; Lioe-Fee de Geus-Oei; Daniele Regge; Daniela-Elena Oprea-Lager; Melvin D'Anastasi; Luc Bidaut; Tobias Bäuerle; Egesta Lopci; Giovanni Cappello; Frederic Lecouvet; Marius Mayerhoefer; Wolfgang G Kunz; Joost J C Verhoeff; Damiano Caruso; Marion Smits; Ralf-Thorsten Hoffmann; Sofia Gourtsoyianni; Regina Beets-Tan; Emanuele Neri; Nandita M deSouza; Christophe M Deroose; Caroline Caramella
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.